Table 3 Comparison of changes in biomarkers during treatment with FYD or PYD
| Â | Change in FYD group (n = 50) | Change in PYD group (n = 50) | P a |
|---|---|---|---|
Waist (cm) | -0.75 ± 2.8 | +1.1 ± 3.6 | 0.005 |
BMI (kg/m2) | -0.17 ± 1.4 | +0.25 ± 0.9 | 0.07 |
Fat mass (%) | +1.1 ± 3.0 | -1.0 ± 5.3 | 0.23 |
Systolic BP (mm Hg) | -7.3 ± 18.5 | -2.5 ± 14.6 | 0.15 |
Diastolic BP (mm Hg) | -3.5 ± 7.8 | -0.63 ± 9.3 | 0.09 |
FSG (mg/dL) | -26.6 ± 45.6 | +6.2 ± 44.8 | < 0.0001 |
Fasting serum insulin (mU/L) | -4.3 ± 9.6 | +3.8 ± 10.3 | < 0.0001 |
HbA1c (%) | -0.9 ± 1.4 | -0.4 ± 1.7 | 0.10 |
Quiccki index | +0.01 ± 0.02 | -0.005 ± 0.02 | < 0.0001 |
TG (mg/dL) | -30.3 ± 81.3 | +0.12 ± 36.8 | 0.01 |
HDL-C (mg/dL) | +2.4 ± 8.3 | -0.6 ± 6.7 | 0.04 |
TC (mg/dL) | -19.4 ± 34.8 | -1.8 ± 31.7 | 0.009 |
LDL-C (mg/dL) | -10.7 ± 24.2 | -1.5 ± 16.9 | 0.02 |
25(OH)D (nmol/L) | +32.6 ± 18.3 | -2.7 ± 16.6 | < 0.0001 |
iPTH (pg/ml) | -11.7 ± 20.6 | 4.3 ± 58.3 | 0.07 |
Microalbumin (mg/dl) | -6.3 ± 51.6 | 0.89 ± 24.8 | 0.38 |
Endothelin (ng/mL) | 0.03 ± 0.55 | 0.35 ± 0.63 | 0.028 |
E-selectin (ng/mL) | -3.8 ± 7.3 | +0.95 ± 8.3 | 0.003 |
MMP-9 (ng/mL) | -2.3 ± 3.7 | +0.44 ± 7.1 | 0.02 |